Apontis Pharma AG (APPH.DE)

EUR 10.05

(0.0%)

Operating Expenses Summary of Apontis Pharma AG

  • Apontis Pharma AG's latest annual operating expenses in 2023 was 23.17 Million EUR , down -62.15% from previous year.
  • Apontis Pharma AG's latest quarterly operating expenses in 2024 Q2 was 5.04 Million EUR , down -7.57% from previous quarter.
  • Apontis Pharma AG reported a annual operating expenses of 31.17 Million EUR in annual operating expenses 2022, down -2.93% from previous year.
  • Apontis Pharma AG reported a annual operating expenses of 32.12 Million EUR in annual operating expenses 2021, up 25.28% from previous year.
  • Apontis Pharma AG reported a quarterly operating expenses of 6.78 Million EUR for 2023 Q2, down -9.0% from previous quarter.
  • Apontis Pharma AG reported a quarterly operating expenses of 5.46 Million EUR for 2023 Q4, down -19.58% from previous quarter.

Annual Operating Expenses Chart of Apontis Pharma AG (2023 - 2019)

Historical Annual Operating Expenses of Apontis Pharma AG (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 23.17 Million EUR -62.15%
2022 31.17 Million EUR -2.93%
2021 32.12 Million EUR 25.28%
2020 25.63 Million EUR -17.86%
2019 31.21 Million EUR 0.0%

Peer Operating Expenses Comparison of Apontis Pharma AG

Name Operating Expenses Operating Expenses Difference
MPH Health Care AG 4.22 Million EUR -448.86%
Dermapharm Holding SE 142.51 Million EUR 83.742%
Evotec SE 222.55 Million EUR 89.589%
MERCK Kommanditgesellschaft auf Aktien 8.82 Billion EUR 99.737%
PharmaSGP Holding SE 50.72 Million EUR 54.319%
SynBiotic SE 1.5 Million EUR -1438.12%